In ovarian cancers with survival follow-up (n = 394), normal MAGEC3 levels were associated with complete response to maximal debulking surgery followed by platinum-based chemotherapy (CR mean 150.5 versus 138.9, two-sample t-test, p = 0.008). This evidence concerns the gene MAGEC3 and ovarian carcinoma.